Encompass Health Corporat...

NYSE: EHC · Real-Time Price · USD
120.29
0.64 (0.53%)
At close: Aug 15, 2025, 3:43 PM

Encompass Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.46B 1.46B 1.41B 1.35B 1.3B 1.32B 1.25B 1.21B 1.19B 1.16B 1.14B 1.09B 1.33B 1.33B 1.32B 1.28B 1.29B 1.23B
Cost of Revenue
767.7M 824.5M 756.8M 792.7M 1.04B 1.06B 1B 53.9M 52M 53.8M 53.9M 51.1M 52.8M 56.1M 54.2M 53.2M 50M 51.9M
Gross Profit
690M 630.9M 648.2M 558.3M 266.1M 257.7M 243M 1.15B 1.14B 1.11B 1.08B 1.04B 1.28B 1.28B 1.26B 1.23B 1.24B 1.18B
Operating Income
115.8M 267M 232.3M 209.1M 215.6M 207.5M 189.9M 114.7M 118.4M 182.6M 188.4M 162.3M 156.8M 181.2M 163.2M 199.5M 177.2M 164.9M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 200K n/a n/a n/a n/a n/a
Pretax Income
236.8M 238.6M 201.4M 183.8M 186M 178.4M 164.8M 145M 151.2M 146.2M 150.9M 107.3M 95.1M 141.3M 147.2M 160.9M 181.8M 167.3M
Net Income
142.1M 151.5M 120.9M 108.2M 114.1M 112.5M 87.6M 85.3M 91.4M 87.7M 89.4M 85.5M 71.3M 87.1M 91.6M 100M 112.8M 106.8M
Selling & General & Admin
59.4M 67.2M 69.2M 54M 50.5M 50.2M 53.1M 722.6M 705.9M 686.2M 670.3M 655.9M 853.4M 845.3M 841.6M 793.8M 782.6M 746M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
433.7M 296.7M 346.7M 295.2M n/a n/a n/a 500K 2.7M 241.8M 233.4M 234.1M 262.2M 248.3M 5.9M 400K 4.6M 1.4M
Operating Expenses
493.1M 363.9M 415.9M 349.2M 50.5M 50.2M 53.1M 973.6M 951.2M 928M 903.7M 890M 1.12B 1.09B 1.08B 1.03B 1.02B 970.8M
Interest Expense
30.4M 31.8M 33M 34.9M 34.3M 35.2M 34.9M 35.9M 36.3M 36.4M 37.5M 38.2M 60.6M 39.6M 40.1M 39.9M 41.8M 42.8M
Selling & Marketing Expenses
n/a 14.9M 14.7M n/a -714.7M -725.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.2B 1.19B 1.17B 1.14B 1.09B 1.11B 1.06B 1.03B 1B 981.8M 957.6M 941.1M 1.17B 1.15B 1.14B 1.09B 1.07B 1.02B
Income Tax Expense
51M 41.6M 37.6M 36M 38.3M 38.3M 37.2M 30.3M 32.8M 31.9M 31.9M 21.8M 23.8M 31.2M 31.5M 34.1M 39.5M 34.5M
Shares Outstanding (Basic)
100.6M 100.5M 100M 99.9M 99.9M 99.8M 99.5M 99.5M 99.5M 99.4M 99.3M 99.2M 99.2M 99.2M 99M 99M 99M 99M
Shares Outstanding (Diluted)
102.2M 102.1M 102.3M 102.1M 102M 102.2M 101.5M 101.4M 101.1M 100.9M 100.8M 100.5M 100.3M 100.2M 100.2M 100.2M 100.2M 100.2M
EPS (Basic)
1.41 1.50 1.20 1.08 1.13 1.12 0.88 0.86 0.91 0.88 0.90 0.86 0.72 0.88 0.92 1.00 1.14 1.08
EPS (Diluted)
1.40 1.48 1.18 1.06 1.12 1.10 0.86 0.84 0.90 0.87 0.88 0.85 0.71 0.87 0.91 1.00 1.13 1.07
EBITDA
347.1M 349.6M 312.4M 297.1M 288.5M 277.8M 260M 248.2M 260.1M 246.5M 251.7M 207.6M 210M 210.3M 253.1M 238.9M 197.2M 272.6M
EBIT
267.2M 270.4M 234.4M 218.7M 215.6M 207.5M 189.9M 180.9M 187.5M 182.6M 188.4M 145.5M 143M 149.6M 187.3M 200.8M 133.8M 210.1M
Depreciation & Amortization
79.9M 79.2M 78M 78.4M 72.9M 70.3M 70.1M 67.3M 72.6M 63.9M 63.3M 62.1M 68.8M 66.2M 65.8M 64.9M 63.4M 62.5M